China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) saw a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 76,353 shares, a decline of 40.9% from the October 31st total of 129,175 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily volume of 481,067 shares, the days-to-cover ratio is presently 0.2 days.

China Pharma (CPHI) traded down $0.01 during trading hours on Monday, hitting $0.18. The company had a trading volume of 78,825 shares, compared to its average volume of 189,533. China Pharma has a 12 month low of $0.15 and a 12 month high of $0.35.

China Pharma (NYSEAMERICAN:CPHI) last released its quarterly earnings data on Wednesday, November 15th. The company reported ($0.05) earnings per share (EPS) for the quarter. China Pharma had a negative net margin of 78.43% and a negative return on equity of 15.88%. The company had revenue of $3.16 million for the quarter. During the same quarter last year, the firm posted ($0.04) EPS.

ILLEGAL ACTIVITY WARNING: “China Pharma Holdings, Inc. (CPHI) Short Interest Update” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at

About China Pharma

China Pharma Holdings, Inc is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co, Ltd. (Helpson) in the People’s Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC.

Receive News & Ratings for China Pharma Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma Holdings Inc. and related companies with's FREE daily email newsletter.